Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo (Q24648007)

25 April 2019

20 August 2019

12 September 2019

20 November 2019

15 December 2019

on focus list of Wikimedia project

29 April 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Neuropathological stageing of Alzheimer-related changes

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

A beta oligomers - a decade of discovery

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

The Clinical Dementia Rating (CDR): current version and scoring rules

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2804478

Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons

7 April 2017

1 reference

12 December 2020

Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication

1 reference

12 December 2020

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

1 reference

12 December 2020

Amyloid imaging in Alzheimer's disease.

1 reference

12 December 2020

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

1 reference

12 December 2020

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.

1 reference

12 December 2020

Will anti-amyloid therapies work for Alzheimer's disease?

1 reference

12 December 2020

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

1 reference

12 December 2020

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease

1 reference

12 December 2020

PET imaging of amyloid deposition in patients with mild cognitive impairment

1 reference

12 December 2020

Imaging amyloid deposition in Lewy body diseases

1 reference

12 December 2020

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

1 reference

12 December 2020

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease

1 reference

12 December 2020

PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment

1 reference

12 December 2020

The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation

1 reference

12 December 2020

Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation.

1 reference

12 December 2020

Frequent amyloid deposition without significant cognitive impairment among the elderly

1 reference

12 December 2020

Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia

1 reference

12 December 2020

Primary progressive aphasia and the growing role of biomarkers in neurological diagnosis

1 reference

12 December 2020

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

1 reference

12 December 2020

Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B

1 reference

12 December 2020

Characterization of PiB binding to white matter in Alzheimer disease and other dementias

1 reference

12 December 2020

Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.

1 reference

12 December 2020

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals

1 reference

12 December 2020

Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics

1 reference

12 December 2020

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies

1 reference

12 December 2020

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

1 reference

12 December 2020

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

1 reference

12 December 2020

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

1 reference

12 December 2020

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

1 reference

12 December 2020

Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid

1 reference

12 December 2020

11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease.

1 reference

12 December 2020

Clinical severity of Alzheimer's disease is associated with PIB uptake in PET.

1 reference

12 December 2020

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

1 reference

12 December 2020

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

1 reference

12 December 2020

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease

1 reference

12 December 2020

In vivo amyloid imaging with PET in frontotemporal dementia.

1 reference

12 December 2020

Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

1 reference

12 December 2020

Absence of cognitive impairment or decline in preclinical Alzheimer's disease

1 reference

12 December 2020

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

12 December 2020

Regional dendritic and spine variation in human cerebral cortex: a quantitative golgi study

1 reference

12 December 2020

Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease

1 reference

12 December 2020

Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease

1 reference

12 December 2020

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

1 reference

12 December 2020

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

1 reference

12 December 2020

In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile

1 reference

12 December 2020

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

1 reference

12 December 2020

Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment

1 reference

12 December 2020

Molecular-imaging probe 2-(1-[6-[(2-fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene) malononitrile labels prion plaques in vitro.

1 reference

12 December 2020

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice

1 reference

12 December 2020

PET imaging of amyloid in Alzheimer's disease.

1 reference

12 December 2020

Plaques, tangles and dementia. A quantitative study

1 reference

12 December 2020

Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes

1 reference

12 December 2020

Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease

1 reference

12 December 2020

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

1 reference

12 December 2020

The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease

1 reference

12 December 2020

Neuroimaging of vessel amyloid in Alzheimer's disease

1 reference

12 December 2020

Frequency of stages of Alzheimer-related lesions in different age categories

1 reference

12 December 2020

Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study

1 reference

12 December 2020

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype

1 reference

12 December 2020

Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.

1 reference

12 December 2020

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

1 reference

12 December 2020

Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy

1 reference

12 December 2020

In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.

1 reference

12 December 2020

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

1 reference

12 December 2020

Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

1 reference

12 December 2020

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis

1 reference

12 December 2020

Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease

1 reference

12 December 2020

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

12 December 2020

Neuropathology of older persons without cognitive impairment from two community-based studies

1 reference

12 December 2020

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

12 December 2020

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease

1 reference

12 December 2020

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease

1 reference

12 December 2020

PET of brain amyloid and tau in mild cognitive impairment.

1 reference

12 December 2020

Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly

1 reference

12 December 2020

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study

1 reference

12 December 2020

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report

1 reference

12 December 2020

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease

1 reference

12 December 2020

2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients

1 reference

12 December 2020

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

1 reference

12 December 2020

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment

1 reference

12 December 2020

Imaging beta-amyloid burden in aging and dementia.

1 reference

12 December 2020

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

1 reference

12 December 2020

Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease

1 reference

12 December 2020

Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.

1 reference

12 December 2020

PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis

1 reference

12 December 2020

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

1 reference

12 December 2020

Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve.

1 reference

12 December 2020

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

1 reference

12 December 2020

Identifiers

DOI

10.3233/BEN-2009-0232

1 reference

10.1155/2009/609839

1 reference

1 reference

1 reference

PubMed publication ID

19847050

1 reference